TORONTO, ON / ACCESSWIRE / May 2, 2017 / NOVADAQ Technologies Inc. NVDQ NDQ will host a conference call and live webcast to discuss the results of the first quarter 2017, to be held Wednesday, May 3, 2017 at 4:30 PM Eastern Time.
Live Event Information
To participate, connect approximately 5 to 10 minutes before the beginning of the event.
- Date, Time: May 3, 2017 at 4:30 PM ET
- Toll Free: 877-407-8031
- International: 201-689-8031
- Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175802 or novadaq.com
Replay Information
The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on June 3, 2017.
- Toll Free: 877-481-4010
- International: 919-882-2331
- Replay ID#: 10307
- Webcast: www.investorcalendar.com or novadaq.com
About Novadaq Technologies Inc.
NOVADAQ's global mission is to enable physicians with point-of-care imaging solutions that provide real-time clinically significant and actionable information to improve care quality and lower healthcare costs. Using NOVADAQ's SPY fluorescence imaging technology, physicians can personalize therapy and achieve optimal results through the precise visualization of blood flow in vessels, micro-vessels, tissue perfusion and critical anatomical structures during the course of treatment. SPY technology enables the delivery of personalized therapies and the achievement of the optimal results for each individual patient. More than 240 peer-reviewed publications demonstrate that the use of SPY technology will reduce post-procedure complication rates and the cost of care for a broad variety of surgical treatments for cancer, cardiovascular diseases and other conditions, helping to ensure that patients benefit from the very best possible treatment and outcome.
SPY Imaging Systems are U.S. Food and Drug Administration 510(k) cleared, Health Canada licensed, CE Marked and registered worldwide for use in multiple surgical specialties and medical applications. The endoscopic version of SPY technology, known as PINPOINT, combines the fluorescence imaging capabilities of SPY with the high definition visible light visualization to establish a new standard in the quality and performance of minimally invasive surgery. NOVADAQ's LUNA System is used to visualize blood flow and tissue perfusion while treating patients with atherosclerotic cardiovascular disease that impairs blood flow to the extremities and increases the risk for the development of complications such as acute and chronic non-healing wounds and limb loss. NOVADAQ is the exclusive worldwide distributor of LifeNet Health's DermACELL acellular tissue products for wound and breast reconstruction surgery.
SOURCE: Investor Network
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
